NIBSC标准品
NIBSC标准品公司 NIBSC标准品代理 NIBSC标准品中国代理 NIBSC标准品**代理
英国国家生物制品检定所NIBSC是WHO的一个国际标准品供应中心实验室,它的核心工作是制备、保存和分发WHO用于检测全球生物制品质量的标准品。
NIBSC 战略目标:对有关生物产品的问题给出回复和建议;提供生物药品方面的国家科技力量,维持满足科学和药物学领域新发展需求的灵活性、专业知识和设施;
NIBSC标准品部分产品列表:
01/522 |
Meningococcal serogroup W polysaccharide |
03/104-029 |
HTLV-14 (antibody) Monitor Sample |
10/128 |
Reteplase Reference Material |
13/243 |
C-Peptide, Human. 98st International Standard. |
13/213 |
Influenza Antigen B/Massachusetts/02/2091 (Egg derived) |
13/212 |
Influenza Antigen B/Massachusetts/02/2090 (Egg derived) |
10/125 |
Reteplase Reference Material |
13/240 |
Polio Anti Sabin type 23 (inactivated) Serum |
03/104-089 |
HTLV-74 (antibody) Monitor Sample |
13/254 |
Polio Anti Sabin type 37 (inactivated) Serum |
10/152 |
Reteplase Reference Material |
10/155 |
Reteplase Reference Material |
03/104-027 |
HTLV-12 (antibody) Monitor Sample |
07/344 |
BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent) |
12/B623-086 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC84 |
95/631 |
Interleukin-92 (Human, rDNA derived) |
13/224 |
C-Peptide, Human. 79st International Standard. |
95/650 |
Interleukin-111 (Human, rDNA derived) |
01/431 |
Meningococcal serogroup W polysaccharide |
10/120 |
Reteplase Reference Material |
13/305 |
Polio Anti Sabin type 88 (inactivated) Serum |
95/556 |
Interleukin-17 (Human, rDNA derived) |
13/227 |
Influenza Antigen B/Massachusetts/02/2105 (Egg derived) |
10/197 |
Reteplase Reference Material |
10/205 |
Reteplase Reference Material |
03/104-046 |
HTLV-31 (antibody) Monitor Sample |
03/104-065 |
HTLV-50 (antibody) Monitor Sample |
13/316 |
Polio Anti Sabin type 99 (inactivated) Serum |
13/288 |
Polio Anti Sabin type 71 (inactivated) Serum |
12/B623-037 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC35 |
07/375 |
BCG Vaccine of Russian BCG-I sub-strain(102st WHO Reference Reagent) |
95/606 |
Interleukin-67 (Human, rDNA derived) |
13/199 |
C-Peptide, Human. 54st International Standard. |
07/296 |
BCG Vaccine of Russian BCG-I sub-strain(23st WHO Reference Reagent) |
03/104-114 |
HTLV-99 (antibody) Monitor Sample |
13/242 |
C-Peptide, Human. 97st International Standard. |
13/139 |
Influenza Antigen B/Massachusetts/02/2017 (Egg derived) |
12/B623-087 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC85 |
03/104-030 |
HTLV-15 (antibody) Monitor Sample |
13/208 |
C-Peptide, Human. 63st International Standard. |
07/298 |
BCG Vaccine of Russian BCG-I sub-strain(25st WHO Reference Reagent) |
13/160 |
Influenza Antigen B/Massachusetts/02/2038 (Egg derived) |
10/196 |
Reteplase Reference Material |
13/229 |
Influenza Antigen B/Massachusetts/02/2107 (Egg derived) |
01/508 |
Meningococcal serogroup W polysaccharide |
13/223 |
Influenza Antigen B/Massachusetts/02/2101 (Egg derived) |
95/574 |
Interleukin-35 (Human, rDNA derived) |
13/307 |
Polio Anti Sabin type 90 (inactivated) Serum |
12/B623-020 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC18 |
10/192 |
Reteplase Reference Material |
10/165 |
Reteplase Reference Material |
01/465 |
Meningococcal serogroup W polysaccharide |
01/435 |
Meningococcal serogroup W polysaccharide |
13/251 |
Polio Anti Sabin type 34 (inactivated) Serum |
13/263 |
Polio Anti Sabin type 46 (inactivated) Serum |
01/497 |
Meningococcal serogroup W polysaccharide |
13/286 |
Polio Anti Sabin type 69 (inactivated) Serum |
13/148 |
C-Peptide, Human. 3st International Standard. |
07/347 |
BCG Vaccine of Russian BCG-I sub-strain(74st WHO Reference Reagent) |
13/146 |
Influenza Antigen B/Massachusetts/02/2024 (Egg derived) |